Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-21

Clinical Trial Update: Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating electroacupuncture plus a four-drug antiemetic regimen (including olanzapine) for chemotherapy-induced nausea and vomiting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Electroacupuncture
  • Olanzapine-contained Four-drug Antiemetic (olanzapine-containing four-drug antiemetic regimen)

Snippet

Sponsor: Feixue Song | Conditions: Electroacupuncture, Olanzapine-contained Four-drug Antiemetic | Phase 3 | Status: RECRUITING